{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:27:55Z","timestamp":1791912475312,"version":"4.3.4"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005156","name":"Alexander von Humboldt Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003157","name":"Myasthenia Gravis Foundation of America Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003157","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007436","name":"Erling-Persson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007436","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ebiom.2026.106322","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T14:12:00Z","timestamp":1780927920000},"page":"106322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Complement C3 inhibition restores myasthenia gravis AChR antibody-mediated muscle pathophysiology"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-2617-2083","authenticated-orcid":false,"given":"Yu-Fang","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7116-0939","authenticated-orcid":false,"given":"Amol Keshavasa","family":"Bhandage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0107-4103","authenticated-orcid":false,"given":"Miriam L.","family":"Fichtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2178-9413","authenticated-orcid":false,"given":"Anna Rostedt","family":"Punga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ebiom.2026.106322_bib1","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.coph.2012.02.002","article-title":"Signaling and aging at the neuromuscular synapse: lessons learnt from neuromuscular diseases","volume":"12","author":"Punga","year":"2012","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106322_bib2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s40259-024-00701-1","article-title":"New and emerging biological therapies for Myasthenia Gravis: a focussed review for clinical decision-making","volume":"39","author":"Gerischer","year":"2025","journal-title":"Biodrugs"},{"issue":"15","key":"10.1016\/j.ebiom.2026.106322_bib3","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1111\/j.1742-4658.2007.05935.x","article-title":"Muscle and neuronal nicotinic acetylcholine receptors. Structure, function and pathogenicity","volume":"274","author":"Kalamida","year":"2007","journal-title":"FEBS J"},{"key":"10.1016\/j.ebiom.2026.106322_bib4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1600-065X.1998.tb01190.x","article-title":"Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor","volume":"163","author":"Tzartos","year":"1998","journal-title":"Immunol Rev"},{"key":"10.1016\/j.ebiom.2026.106322_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.596981","article-title":"Myasthenia gravis: autoantibody specificities and their role in MG management","volume":"11","author":"Lazaridis","year":"2020","journal-title":"Front Neurol"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106322_bib6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1474-4422(21)00357-4","article-title":"Advances in the understanding of disease mechanisms of autoimmune neuromuscular junction disorders","volume":"21","author":"Huijbers","year":"2022","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106322_bib7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/nyas.13522","article-title":"Myasthenia gravis: the role of complement at the neuromuscular junction","volume":"1412","author":"Howard","year":"2018","journal-title":"Ann Ny Acad Sci"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106322_bib8","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200436","article-title":"AChR autoantibody pathogenic properties are heterogeneously distributed and undergo temporal changes among patients with Myasthenia gravis","volume":"12","author":"Khani-Habibabadi","year":"2025","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106322_bib9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12551-013-0135-x","article-title":"The excitation-contraction coupling mechanism in skeletal muscle","volume":"6","author":"Calderon","year":"2014","journal-title":"Biophys Rev"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106322_bib10","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a003947","article-title":"Voltage-gated calcium channels","volume":"3","author":"Catterall","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106322_bib11","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/2211-5463.12965","article-title":"T-type calcium channel blockade induces apoptosis in C2C12 myotubes and skeletal muscle via endoplasmic reticulum stress activation","volume":"10","author":"Chen","year":"2020","journal-title":"FEBS Open Bio"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106322_bib12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.stem.2015.10.002","article-title":"Functional connectivity under optogenetic control allows modeling of human neuromuscular disease","volume":"18","author":"Steinbeck","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ebiom.2026.106322_bib13","article-title":"A 3D culture model of innervated human skeletal muscle enables studies of the adult neuromuscular junction","volume":"8","author":"Bakooshli","year":"2019","journal-title":"Elife"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106322_bib14","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1474-4422(23)00080-7","article-title":"Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study","volume":"22","author":"Howard","year":"2023","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106322_bib15","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ana.410430408","article-title":"Purified IgG from seropositive and seronegative patients with mysasthenia gravis reversibly blocks currents through nicotinic acetylcholine receptor channels","volume":"43","author":"Bufler","year":"1998","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106322_bib16","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1212\/WNL.54.2.474","article-title":"Mechanism of block of nicotinic acetylcholine receptor channels by purified IgG from seropositive patients with myasthenia gravis","volume":"54","author":"Jahn","year":"2000","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106322_bib17","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/jnnp-2019-322640","article-title":"Myasthenia gravis AChR antibodies inhibit function of rapsyn-clustered AChRs","volume":"91","author":"Cetin","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106322_bib18","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00401-023-02603-y","article-title":"Individual myasthenia gravis autoantibody clones can efficiently mediate multiple mechanisms of pathology","volume":"146","author":"Pham","year":"2023","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106322_bib19","first-page":"851","article-title":"Visualization and characterization of complement activation in acetylcholine receptor antibody seropositive myasthenia gravis","volume":"70","author":"Huang","year":"2024","journal-title":"Muscle Nerve"},{"issue":"1\u20132","key":"10.1016\/j.ebiom.2026.106322_bib20","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jim.2007.09.017","article-title":"Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning","volume":"329","author":"Tiller","year":"2008","journal-title":"J Immunol Methods"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106322_bib21","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.127167","article-title":"Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients","volume":"4","author":"Takata","year":"2019","journal-title":"Jci Insight"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106322_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208981","article-title":"Expression of calcium release-activated and voltage-gated calcium channels genes in peripheral blood mononuclear cells is altered in pregnancy and in type 1 diabetes","volume":"13","author":"Bhandage","year":"2018","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.ebiom.2026.106322_bib23","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124299","article-title":"iPSC-derived functional human neuromuscular junctions model the pathophysiology of neuromuscular diseases","volume":"4","author":"Lin","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.ebiom.2026.106322_bib24","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.60528","article-title":"A motogenic GABAergic system of mononuclear phagocytes facilitates dissemination of coccidian parasites","volume":"9","author":"Bhandage","year":"2020","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106322_bib25","first-page":"459","article-title":"Measuring resting membrane potential using the fluorescent voltage reporters DiBAC4(3) and CC2-DMPE","volume":"2012","author":"Adams","year":"2012","journal-title":"Cold Spring Harb Protoc"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106322_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002029","article-title":"Electrochemical regulation of budding yeast polarity","volume":"12","author":"Haupt","year":"2014","journal-title":"PLoS Biol"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106322_bib27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0009-3084(94)90035-3","article-title":"Characterization of the steady-state and dynamic fluorescence properties of the potential-sensitive dye bis-(1,3-dibutylbarbituric acid)trimethine oxonol (Dibac4(3)) in model systems and cells","volume":"69","author":"Epps","year":"1994","journal-title":"Chem Phys Lipids"},{"issue":"17","key":"10.1016\/j.ebiom.2026.106322_bib28","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1007\/s00018-008-8080-8","article-title":"Alpha-actinin structure and regulation","volume":"65","author":"Sjoblom","year":"2008","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106322_bib29","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/sj.bjp.0702941","article-title":"Activation of muscle nicotinic acetylcholine receptor channels by nicotinic and muscarinic agonists","volume":"128","author":"Akk","year":"1999","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106322_bib30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2125.1986.tb05166.x","article-title":"Effects of locally administered anticholinesterase agents on the secretory response of human eccrine sweat glands to acetylcholine and carbachol","volume":"21","author":"Longmore","year":"1986","journal-title":"Br J Clin Pharmacol"},{"issue":"2\u20133","key":"10.1016\/j.ebiom.2026.106322_bib31","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-3083.2007.01959.x","article-title":"CD59 efficiently protects human NT2-N neurons against complement-mediated damage","volume":"66","author":"Pedersen","year":"2007","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.ebiom.2026.106322_bib32","first-page":"273","article-title":"Compstatin: a complement inhibitor on its way to clinical application","volume":"632","author":"Ricklin","year":"2008","journal-title":"Adv Exp Med Biol"},{"issue":"13","key":"10.1016\/j.ebiom.2026.106322_bib33","doi-asserted-by":"crossref","first-page":"7627","DOI":"10.1073\/pnas.97.13.7627","article-title":"T-type alpha 1H Ca2+ channels are involved in Ca2+ signaling during terminal differentiation (fusion) of human myoblasts","volume":"97","author":"Bijlenga","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106322_bib34","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00424-020-02368-3","article-title":"Skeletal muscle Ca(V)1.1 channelopathies","volume":"472","author":"Flucher","year":"2020","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.ebiom.2026.106322_bib35","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13395-014-0027-1","article-title":"Ca(2+) permeation and\/or binding to CaV1.1 fine-tunes skeletal muscle Ca(2+) signaling to sustain muscle function","volume":"5","author":"Lee","year":"2015","journal-title":"Skelet Muscle"},{"key":"10.1016\/j.ebiom.2026.106322_bib36","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1113\/jphysiol.1988.sp017183","article-title":"Post-natal disappearance of transient calcium channels in mouse skeletal muscle: effects of denervation and culture","volume":"401","author":"Gonoi","year":"1988","journal-title":"J Physiol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106322_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-23703-x","article-title":"A link between agrin signalling and Ca(v)3.2 at the neuromuscular junction in spinal muscular atrophy","volume":"12","author":"Delers","year":"2022","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106322_bib38","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1073\/pnas.74.5.2130","article-title":"Accelerated degradation of acetylcholine receptor from cultured rat myotubes with myasthenia gravis sera and globulins","volume":"74","author":"Appel","year":"1977","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4289","key":"10.1016\/j.ebiom.2026.106322_bib39","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1126\/science.850793","article-title":"Myasthenic immunoglobulin accelerates acetylcholine receptor degradation","volume":"196","author":"Kao","year":"1977","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106322_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-68185-x","article-title":"AChR antibodies show a complex interaction with human skeletal muscle cells in a transcriptomic study","volume":"10","author":"Hong","year":"2020","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106322_bib41","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0022-2836(02)00381-9","article-title":"Activation of the nicotinic acetylcholine receptor involves a switch in conformation of the alpha subunits","volume":"319","author":"Unwin","year":"2002","journal-title":"J Mol Biol"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106322_bib42","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0896-6273(95)90037-3","article-title":"Three-dimensional location of the main immunogenic region of the acetylcholine receptor","volume":"15","author":"Beroukhim","year":"1995","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106322_bib43","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0896-6273(00)80118-X","article-title":"Rapsyn clusters and activates the synapse-specific receptor tyrosine kinase MuSK","volume":"16","author":"Gillespie","year":"1996","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106322_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108327","article-title":"Direct proof of the in vivo pathogenic role of the AChR autoantibodies from myasthenia gravis patients","volume":"9","author":"Kordas","year":"2014","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/j.ebiom.2026.106322_bib45","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jneuroim.2007.06.014","article-title":"Isolation and functional characterization of anti-acetylcholine receptor subunit-specific autoantibodies from myasthenic patients: receptor loss in cell culture","volume":"189","author":"Sideris","year":"2007","journal-title":"J Neuroimmunol"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106322_bib46","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00401-022-02493-6","article-title":"Receptor clustering and pathogenic complement activation in myasthenia gravis depend on synergy between antibodies with multiple subunit specificities","volume":"144","author":"Rose","year":"2022","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ebiom.2026.106322_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.809106","article-title":"A recombinant acetylcholine receptor alpha1 subunit extracellular domain is a promising new drug candidate for treatment of Myasthenia gravis","volume":"13","author":"Lazaridis","year":"2022","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106322_bib48","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000214150","article-title":"Subunit-specific immunodominance in clinically distinct populations with AChR+ Myasthenia gravis: a multiparametric cross-sectional analysis","volume":"105","author":"Oved","year":"2025","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106322_bib49","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0014-5793(88)80442-3","article-title":"Increased levels of acetylcholine receptor alpha-subunit mRNA in experimental autoimmune myasthenia gravis","volume":"233","author":"Asher","year":"1988","journal-title":"FEBS Lett"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106322_bib50","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/mus.21371","article-title":"Acetylcholine receptor-alpha subunit expression in myasthenia gravis: a role for the autoantigen in pathogenesis?","volume":"40","author":"Sheng","year":"2009","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106322_bib51","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1172\/JCI1248","article-title":"Regulation of acetylcholine receptor gene expression in human myasthenia gravis muscles. Evidences for a compensatory mechanism triggered by receptor loss","volume":"102","author":"Guyon","year":"1998","journal-title":"J Clin Invest"},{"issue":"33","key":"10.1016\/j.ebiom.2026.106322_bib52","doi-asserted-by":"crossref","first-page":"8616","DOI":"10.1021\/bi00084a032","article-title":"A high-affinity site for acetylcholine occurs close to the alpha-gamma subunit interface of Torpedo nicotinic acetylcholine receptor","volume":"32","author":"Dunn","year":"1993","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106322_bib53","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1523\/JNEUROSCI.20-03-00919.2000","article-title":"Local control of acetylcholinesterase gene expression in multinucleated skeletal muscle fibers: individual nuclei respond to signals from the overlying plasma membrane","volume":"20","author":"Rossi","year":"2000","journal-title":"J Neurosci"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106322_bib54","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1083\/jcb.200709086","article-title":"Nicotinic acetylcholine receptor is internalized via a Rac-dependent, dynamin-independent endocytic pathway","volume":"181","author":"Kumari","year":"2008","journal-title":"J Cell Biol"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106322_bib55","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1084\/jem.160.5.1558","article-title":"Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes","volume":"160","author":"Medof","year":"1984","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106322_bib56","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/s41467-023-36441-z","article-title":"Structural basis for membrane attack complex inhibition by CD59","volume":"14","author":"Couves","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106322_bib57","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200057","article-title":"CD59 expression in skeletal muscles and its role in Myasthenia gravis","volume":"10","author":"Iwasa","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106322_bib58","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/1744666X.2022.2082946","article-title":"Role of complement, anti-complement therapeutics, and other targeted immunotherapies in myasthenia gravis","volume":"18","author":"Dalakas","year":"2022","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.ebiom.2026.106322_bib59","article-title":"Complement inhibition by C3-siRNA treatment prevents AChR loss and reduces complement activation in the rat Passive Transfer Myasthenia Gravis (PTMG)","author":"Sch\u00f6ttler","year":"2025","journal-title":"bioRxiv"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106322_bib60","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/ene.15730","article-title":"Complement activation profiles in anti-acetylcholine receptor positive myasthenia gravis","volume":"30","author":"Stascheit","year":"2023","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ebiom.2026.106322_bib61","article-title":"On the road to blood biomarkers in myasthenia gravis (MG): beyond clinical scales","author":"Bhandage","year":"2025","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.ebiom.2026.106322_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.581097","article-title":"The structure, function, and physiology of the fetal and adult acetylcholine receptor in muscle","volume":"13","author":"Cetin","year":"2020","journal-title":"Front Mol Neurosci"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426002045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426002045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T08:11:08Z","timestamp":1783498268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396426002045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":62,"alternative-id":["S2352396426002045"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106322","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement C3 inhibition restores myasthenia gravis AChR antibody-mediated muscle pathophysiology","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106322","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106322"}}